Form 4: Amprius Technologies Executive Jonathan Bornstein Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Jonathan Bornstein, President of Amprius Lab, exercised stock options and sold shares of Amprius Technologies common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On March 5th and 6th, 2024, Jonathan Bornstein, President of Amprius Lab, exercised stock options to acquire 109,800 and 40,200 shares of Amprius Technologies common stock, respectively, at a price of $0.05 per share.
  • Concurrently, Bornstein sold the same number of shares on the same days at average prices of $2.9186 and $2.7756, respectively.
  • These transactions were executed automatically under a Rule 10b5-1 trading plan adopted on May 12, 2023.
  • Following these transactions, Bornstein continues to beneficially own 1,133,851 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading plan and do not necessarily reflect a change in the executive's view of the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It is common for executives to utilize 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.

Key Dates

DateDescription
05/12/2023Date of adoption of Rule 10b5-1 trading plan
09/14/2022Date stock options were granted
03/05/2024Date of first transaction (exercise and sale of shares)
03/06/2024Date of second transaction (exercise and sale of shares)
03/07/2024Date of Form 4 filing
03/15/2027Expiration date of stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.